{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:42:44Z","timestamp":1782783764544,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.vaccine.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T08:22:02Z","timestamp":1653985322000},"page":"3954-3962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of performance of varicella vaccines via infectious disease modeling"],"prefix":"10.1016","volume":"40","author":[{"given":"Matthew","family":"Pillsbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Carias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6176-0677","authenticated-orcid":false,"given":"Salome","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjiri","family":"Pawaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.05.003_b0005","doi-asserted-by":"crossref","unstructured":"Heininger U, Seward JF. Varicella. Lancet. 2006 Oct 14;368(9544):1365-76. https:\/\/doi.org\/10.1016\/S0140-6736(06)69561-5. Erratum in: Lancet. 2007 Feb 17;369(9561):558. PMID: 17046469.","DOI":"10.1016\/S0140-6736(06)69561-5"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.003_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.003_b0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00006454-200210000-00009","article-title":"Hospitalizations for varicella in the United States, 1988 to 1999","volume":"21","author":"Galil","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.vaccine.2022.05.003_b0020","doi-asserted-by":"crossref","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.003_b0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10198-003-0200-7","article-title":"The burden of varicella in Germany. Potential risks and economic impact","volume":"5","author":"Banz","year":"2004","journal-title":"Eur J Health Econ"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.003_b0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","article-title":"Cost-effectiveness of varicella vaccination programs: an update of the literature","volume":"7","author":"Rozenbaum","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"10.1016\/j.vaccine.2022.05.003_b0035","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2022.05.003_b0040","doi-asserted-by":"crossref","first-page":"e0220921","DOI":"10.1371\/journal.pone.0220921","article-title":"Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model","volume":"14","author":"Wolfson","year":"2019","journal-title":"PLoS ONE"},{"issue":"1336","key":"10.1016\/j.vaccine.2022.05.003_b0045","article-title":"Imperfect vaccines and herd immunity to HIV","volume":"253","author":"McLean","year":"1993","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2022.05.003_b0050","unstructured":"Wolfson LJ, Daniels VJ, Kyle J, Burgess CR. Value of Information: Correctly Parameterizing Vaccine Performance in Model-Based Cost-Effectiveness Assessments of Varicella Vaccination. In: EPIDEMICS6: Sixth international conference on infectious disease dynamics; November 29, 2017\u2013December 1, 2017. Sitges, Spain; 2017."},{"key":"10.1016\/j.vaccine.2022.05.003_b0055","unstructured":"GlaxoSmithKline. Evaluate vaccine against chickenpox and a combined vaccine against 4 viral childhood diseases: measles, mumps, rubella and chickenpox updated: November 11, 2021. Available from: https:\/\/www.gsk-studyregister.com\/en\/trial-details\/?id=100388."},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.003_b0060","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.003_b0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.003_b0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1473-3099(18)30716-3","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial","volume":"19","author":"Povey","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.003_b0075","unstructured":"U.S. Centers for Disease Control and Prevention. Vaccines and preventable diseases [updated April 28, 2021]. Available from: https:\/\/www.cdc.gov\/vaccines\/vpd\/varicella\/hcp\/about-vaccine.html."},{"key":"10.1016\/j.vaccine.2022.05.003_b0080","series-title":"All of statistics: a concise course in statistical inference","author":"Wasserman","year":"2010"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.003_b0085","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"10.1016\/j.vaccine.2022.05.003_b0090","unstructured":"Wolfram Research. NDSolve 1991 [updated 2019]. Available from: https:\/\/reference.wolfram.com\/language\/ref\/NDSolve.html."},{"key":"10.1016\/j.vaccine.2022.05.003_b0095","unstructured":"Wolfram Research. FindMaximum 2003 [updated 2014]. Available from: https:\/\/reference.wolfram.com\/language\/ref\/FindMaximum.html."},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.003_b0100","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2022.05.003_b0105","doi-asserted-by":"crossref","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2022.05.003_b0110","unstructured":"Pawaskar M, Siddiqui MK, Takyar J, Fergie J. Relative efficacy of varicella vaccines: a systematic literature review and network meta-analysis of randomized controlled trials. In: ESPID: 38th annual meeting; October 26, 2020-October 29, 2020. Virtual meeting; 2020."},{"key":"10.1016\/j.vaccine.2022.05.003_b0115","doi-asserted-by":"crossref","DOI":"10.2147\/CEOR.S229685","article-title":"The cost-effectiveness of universal varicella vaccination in Italy: a model-based assessment of vaccination strategies","volume":"12","author":"Azzari","year":"2020","journal-title":"ClinicoEcon Outcomes Res"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.003_b0120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","article-title":"Comparative varicella vaccine effectiveness during outbreaks in day-care centres","volume":"28","author":"Spackova","year":"2010","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2022.05.003_b0125","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014","volume":"89","author":"World Health Organization (WHO)","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.003_b0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/2051013613515621","article-title":"Successes and challenges in varicella vaccine","volume":"2","author":"Papaloukas","year":"2014","journal-title":"Ther Adv Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.003_b0135","doi-asserted-by":"crossref","first-page":"e0193838","DOI":"10.1371\/journal.pone.0193838","article-title":"Varicella zoster virus transmission dynamics in Vojvodina, Serbia","volume":"13","author":"Medi\u0107","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.003_b0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S0950268804002754","article-title":"Seroprevalence and force of infection of varicella-zoster virus in Luxembourg","volume":"132","author":"Mossong","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.003_b0145","doi-asserted-by":"crossref","first-page":"e0163636","DOI":"10.1371\/journal.pone.0163636","article-title":"Estimating age-specific immunity and force of infection of varicella zoster virus in Norway using mixture models","volume":"11","author":"Del Fava","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.05.003_b0150","unstructured":"Lopez A, Leung J, Schmid S, Marin M Varicella. In: Roush S.W., Baldy L.M., Kirkconnell Hall M.A., editors. Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention and Department of Health and Human Services. https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt17-varicella.html."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:13:29Z","timestamp":1759403609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22005746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0264410X22005746"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of performance of varicella vaccines via infectious disease modeling","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}